NFKB1 and cholestasis: Sanhuang xiexin decoction (SXD) was able to modulate the gut-liver axis immunomodulation to ameliorate DSS-induced colitis secondary to hepatic injury, and attenuate hepatic inflammation and cholestasis by improving TLR4-NF-κB and bile acid metabolic pathways (212).